Work

Validation of the Serial Use of the Myelofibrosis Symptom Assessment Form (MF-SAF) for Measuring Symptomatic Improvement: Performance in 86 Myelofibrosis Patients On INCB018424 Clinical Trial.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.3917.3917

Authors: Ruben A. Mesa, Hagop Kantarjian, Ayalew Tefferi, Richard Levy, Kris Vaddi, Susan Erickson-Viitanen, Deborah A. Thomas, Jorge Cortes-Franco, Gautam Borthakur, Animesh D. Pardanani, Zeev Estrov, Srdan Verstovsek

Institutions: Mayo Clinic in Arizona, The University of Texas MD Anderson Cancer Center, Mayo Clinic, Incyte (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979321829

FWCI: 1.315

Cites:

Cited by: 8

Related to: 10